CytoDyn Investors Challenge Director Removal Rule In Del.

By Jeff Montgomery (September 23, 2021, 5:16 PM EDT) -- Two stockholders in late-stage biotech venture CytoDyn Inc. sued the company in Delaware Chancery Court late Wednesday in a challenge to the company's "for cause only" restriction on director removals, the latest in a run of bitter litigation over company control.

The suit noted that the provision violates Delaware's general corporation law, and it joins a recent spate of suits contesting alleged company attempts to snuff dissident stockholder objections to director compensation, board nominating requirements and overall management.

Shareholders Robert Schielke and Lois J. Schielke said in their suit that, for CytoDyn and companies like it, "no exception applies to the...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!